학술논문

Role of tumor cells contaminating the graft in breast cancer recurrence after high-dose chemotherapy.
Document Type
Article
Source
Bone Marrow Transplantation. 7/15/97, Vol. 20 Issue 2, p167. 3p.
Subject
*TUMORS
*TRANSPLANTATION immunology
*BREAST cancer
*DRUG therapy
Language
ISSN
0268-3369
Abstract
One of the possible drawbacks to autologous stem cell transplantation in breast cancer (BC) patients is the potential for tumor contamination in the transplanted product. We present a patient with advanced disease who received high-dose chemotherapy (HDC) and PBPC support as consolidation therapy after achieving complete remission with standard-dose first-line treatment, and suffered recurrence of the disease 6 months after transplantation. Retrospective analysis revealed the presence of contaminating cells in the leukapheretic product, and clinical evidence suggested a role for these cells in the tumor relapse. [ABSTRACT FROM AUTHOR]